Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer

Urology

Volumn 54, Issue 1, 1999, Pages 50-55

  Uǧur Mungan, Erdener Özer M ^a   Tuna, Burçin ^a   Kazimoǧlu, Hatem ^a   Yörükoǧlu, Kutsal ^a   Kirkali, Ziya ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CATHEPSIN D; COLLAGEN TYPE 4; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STEREOLOGY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CATHEPSIN D; COLLAGEN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 0033168345     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00026-6     Document Type: Article

References (27)

1. Bane BL, Rao JY, and Hemstreet GP: Pathology and staging of bladder cancer. Semin Oncol 23: 546-570, 1996.
2. Dalesio O, Schulman CC, Sylvester R, et al, for the Genitourinary Tract Cancer Cooperative Group: Prognostic factors in superficial bladder tumors. A study of the European organization for research on treatment of cancer. J Urol 129: 730-733, 1983.
3. Jakse G, Loidl W, Seeber G, et al: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavourable tumor? J Urol 137: 39-43, 1987.
4. Lapham RL, Grignon D, and Ro JY: Pathologic prognos-tic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 14: 109-122, 1997.
5. Stein JP, Grossleld GD, Ginsberg DA, et al: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 160: 645-659, 1998.
6. Craft PS, and Harris AL: Clinical prognostic significance of tumour angiogenesis. Ann Oncol 5: 305-311, 1994.
7. Philp EA, Stephenson TJ, and Reed NWR: Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 77: 352-357, 1996.
8. Chauhan SS, Goldstein LJ, and Gottesman MM: Expression of cathepsin L in human tumors. Cancer Res 51: 1478-1481, 1991.
9. Schapers RFM, Pauwels RPE, Havenith MG, et al: Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 66: 2583-2588, 1990.
10. Dickinson AJ, Fox SB, Newcomb PV, et al: An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. J Urol 154: 237-241, 1995.
11. Mostofi FK, Sobin LH, and Torloni H: Histologic typing of urinary bladder tumours, in World Health Organization: International Classification of Tumours, Genova, 1973, No 10.
12. Spissl B, Beahrs O, Hermanek P, et al: TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. Berlin, Springer Verlag by UICC, 1992.
13. Taylor CR, and Cote RJ: Immunomicroscopy: a diagnostic tool for the surgical pathologist, in Major Problems in Pathology Series, 2nd ed. Philadelphia, WB Saunders, 1994, vol 19, p 421.
14. Gilcrease MZ, Truong L, and Brown RW: Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastases of renal cell carcinoma. Hum Pathol 27: 1355-1360, 1996.
15. Alampi G, Galli C, Mastichelli M, et al: Distribution of basement membrane antigens in bladder carcinomas: an additional prognostic parameter. Immunohistochemical study. Arch Anat Cytol Pathol 37: 224-230, 1989.
16. Weibel ER: Principles and methods for the morphometric study of the lung and the other organs. Lab Invest 12: 131-155, 1963.
17. Heney NM: Natural history of superficial bladder cancer. Urol Clin North Am 19: 429-433, 1992.
18. Vicente J, Laguna MP, Duarte D, et al: Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours. Br J Urol 68: 380-382, 1991.
19. Abel PD: Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy. Br J Urol 72: 135-142, 1993.
20. Dickinson AJ, Fox SB, Persad RA, et al: Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74: 762-766, 1994.
21. Bochner BH, Cote RJ, Weidner N, et al: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87: 1603-1612, 1995.
22. Earth PJ, Weingartner K, Köhler HH, et al: Assessment of vascularization in prostatic carcinoma: a morphometric investigation. Hum Pathol 27: 1306-1310, 1996.
23. Mungan U, Kirkali G, Çelebi I, et al: Significance of serum laminin Pl values in patients with transitional cell carcinoma of the bladder. Urology 48: 490-500, 1996.
24. Deen S, and Ball RY: Basement membrane and extracellular interstitial matrix components in bladder neoplasia: evidence of angiogenesis. Histopathology 25: 475-481, 1994.
25. Daher N, Abourachid H, Bove N, et al: Collagen IV staining pattern in bladder carcinomas: relationship to prognosis. Br J Cancer 55: 665-671, 1987.
26. Iuzimi T, Ilyama T, Tanaka W, et al: Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder. Urol Int 59: 81-87, 1997.
27. Lipponen PK: Expression of cathepsin D in transitional cell bladder tumors. J Pathol 178: 59-64, 1996.